The ACLU Is Accusing Nebraska of Illegally Obtaining Death Penalty Drug

It’s unclear how the state acquired the fentanyl it wants to use for lethal injection.

Nebraska's death chamberNate Jenkins/AP

Fight disinformation. Get a daily recap of the facts that matter. Sign up for the free Mother Jones newsletter.

A new letter to the Drug Enforcement Agency from the American Civil Liberties Union of Nebraska is calling on the DEA to investigate Nebraska State Penitentiary officials for allegedly illegally obtaining drugs to use in lethal injections.

Records obtained by the ACLU of Nebraska show that the Nebraska’s government acquired fentanyl, a Schedule II controlled substance without the proper DEA approval, potentially acquiring the drugs through illegal means. According to the ACLU of Nebraska, prison officials obtained the drugs in order execute Jose Sandoval and Carey Moore. “The state of Nebraska can’t continue to cut corners and play fast and loose with federal law,” says Danielle Conrad, the executive director of the state ACLU.

Nebraska hasn’t carried out an execution in more than two decades. In 2015, the state legislature voted to repeal the death penalty, but after a successful ballot initiative in 2016, backed by Republican Gov. Pete Ricketts and funded by his GOP megadonor father Joe Ricketts, Nebraskans voted overwhelmingly to bring it back. Facing the same drug shortage that has plagued death penalty states, Nebraska proposed using fentanyl, the drug that’s playing an outsized role in the opioid epidemic, in its lethal injection cocktail. The drug has never been used in a lethal injection. In late 2017, the state issued a death warrant for Sandoval saying fentanyl would be one of the drugs used to kill him followed by a warrant for Moore in January. The executions have not yet been scheduled.

In order to regulate controlled substances, the DEA gives registration numbers to different individuals and institutions that regularly handle drugs such as hospitals and researchers. It is illegal for an institution to possess a drug without the proper DEA registration number. The Nebraska State Penitentiary’s registration numbers only allows it to handle Schedule IIIN, which includes drugs like testosterone and the anesthetic ketamine, and Schedule IV, which includes anti-anxiety drugs like Xanax and Valium.

The prison facilities also includes a hospital, which is legally able to dispense a wider class of drugs, including fentanyl. DEA regulations says that the hospital can only give these drugs to patients. So, while the hospital theoretically has access to fentanyl, it cannot dispense those drugs to prisoners on death row who are not patients.

Nebraska’s proposed lethal cocktail calls for diazepam, a sedative, and fentanyl to render the prisoner unconscious, cisatracurium to paralyze the inmate, and finally potassium chloride to stop the heart. But medical experts say that if the first two drugs aren’t administered properly, the paralytic would leave the inmate unable to scream or move to indicate pain. Nevada has also proposed using the same protocol. 

This isn’t the first time Nebraska has come under fire for trying to obtain lethal injection drugs. In 2015, the state tried to import sodium thiopental, a drug that renders the inmate unconscious, from a broker in India. The US Food and Drug Administration barred the shipment because the agency does not approve the drug.

It’s unclear how the state managed to obtain fentanyl, raising questions about its quality. Much to the dismay of the state’s ACLU, Nebraska has refused to comply with open records requests. The civil liberties group has filed a lawsuit to compel the state to reveal its drug sources. “The bottom line is this is just the latest in a long series of illegal efforts by the state to kill someone on death row,”says Amy Miller, the ACLU of Nebraska’s legal director.

Read the letter below.

HERE ARE THE FACTS:

Our fall fundraising drive is off to a rough start, and we very much need to raise $250,000 in the next couple of weeks. If you value the journalism you get from Mother Jones, please help us do it with a donation today.

As we wrote over the summer, traffic has been down at Mother Jones and a lot of sites with many people thinking news is less important now that Donald Trump is no longer president. But if you're reading this, you're not one of those people, and we're hoping we can rally support from folks like you who really get why our reporting matters right now. And that's how it's always worked: For 45 years now, a relatively small group of readers (compared to everyone we reach) who pitch in from time to time has allowed Mother Jones to do the type of journalism the moment demands and keep it free for everyone else.

Please pitch in with a donation during our fall fundraising drive if you can. We can't afford to come up short, and there's still a long way to go by November 5.

payment methods

ONE MORE QUICK THING:

Our fall fundraising drive is off to a rough start, and we very much need to raise $250,000 in the next couple of weeks. If you value the journalism you get from Mother Jones, please help us do it with a donation today.

As we wrote over the summer, traffic has been down at Mother Jones and a lot of sites with many people thinking news is less important now that Donald Trump is no longer president. But if you're reading this, you're not one of those people, and we're hoping we can rally support from folks like you who really get why our reporting matters right now. And that's how it's always worked: For 45 years now, a relatively small group of readers (compared to everyone we reach) who pitch in from time to time has allowed Mother Jones to do the type of journalism the moment demands and keep it free for everyone else.

Please pitch in with a donation during our fall fundraising drive if you can. We can't afford to come up short, and there's still a long way to go by November 5.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate